Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel J Vidal

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Human Vaccines & Immunotherapeutics|March 22, 2024
COVID-19 vaccines: Immune correlates and clinical outcomesShant H Mahrokhian, Lisa H Tostanoski, Samuel J Vidal, et al.
Open Forum Infectious Diseases|October 23, 2020
Omadacycline for the Treatment of <i>Mycobacterium abscessus</i> Disease: A Case SeriesJeffrey C Pearson, Brandon Dionne, Aaron Richterman, et al.
Journal of Visualized Experiments : Jove|April 2, 2014
Isolation of cancer stem cells from human prostate cancer samplesSamuel J Vidal, S Aidan Quinn, Janis de la Iglesia-Vicente, et al.
Plos Pathogens|April 8, 2022
Ad26.COV2.S prevents upregulation of SARS-CoV-2 induced pathways of inflammation and thrombosis in hamsters and rhesus macaquesMalika Aid, Samuel J Vidal, Cesar Piedra-Mora, et al.
Iscience|June 28, 2023
Attenuated <i>Mycobacterium tuberculosis</i> vaccine protection in a low-dose murine challenge modelSamuel J Vidal, Daniel Sellers, Jingyou Yu, et al.
Cancer Cell|September 15, 2012
Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cellsJosep Domingo-Domenech, Samuel J Vidal, Veronica Rodriguez-Bravo, et al.
Journal of Virology|April 24, 2021
Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic SeraSamuel J Vidal, Ai-Ris Y Collier, Jingyou Yu, et al.
Cell|September 16, 2025
Mining the CD4 antigen repertoire for next-generation tuberculosis vaccinesSamuel J Vidal, Ninaad Lasrado, Lisa H Tostanoski, et al.
Cancer Cell|February 12, 2015
A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancerSamuel J Vidal, Veronica Rodriguez-Bravo, S Aidan Quinn, et al.
Nature|December 7, 2021
Long-acting capsid inhibitor protects macaques from repeat SHIV challengesSamuel J Vidal, Elena Bekerman, Derek Hansen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Human Vaccines & Immunotherapeutics|March 22, 2024
COVID-19 vaccines: Immune correlates and clinical outcomesShant H Mahrokhian, Lisa H Tostanoski, Samuel J Vidal, et al.
Open Forum Infectious Diseases|October 23, 2020
Omadacycline for the Treatment of <i>Mycobacterium abscessus</i> Disease: A Case SeriesJeffrey C Pearson, Brandon Dionne, Aaron Richterman, et al.
Journal of Visualized Experiments : Jove|April 2, 2014
Isolation of cancer stem cells from human prostate cancer samplesSamuel J Vidal, S Aidan Quinn, Janis de la Iglesia-Vicente, et al.
Plos Pathogens|April 8, 2022
Ad26.COV2.S prevents upregulation of SARS-CoV-2 induced pathways of inflammation and thrombosis in hamsters and rhesus macaquesMalika Aid, Samuel J Vidal, Cesar Piedra-Mora, et al.
Iscience|June 28, 2023
Attenuated <i>Mycobacterium tuberculosis</i> vaccine protection in a low-dose murine challenge modelSamuel J Vidal, Daniel Sellers, Jingyou Yu, et al.
Cancer Cell|September 15, 2012
Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cellsJosep Domingo-Domenech, Samuel J Vidal, Veronica Rodriguez-Bravo, et al.
Journal of Virology|April 24, 2021
Correlates of Neutralization against SARS-CoV-2 Variants of Concern by Early Pandemic SeraSamuel J Vidal, Ai-Ris Y Collier, Jingyou Yu, et al.
Cell|September 16, 2025
Mining the CD4 antigen repertoire for next-generation tuberculosis vaccinesSamuel J Vidal, Ninaad Lasrado, Lisa H Tostanoski, et al.
Cancer Cell|February 12, 2015
A targetable GATA2-IGF2 axis confers aggressiveness in lethal prostate cancerSamuel J Vidal, Veronica Rodriguez-Bravo, S Aidan Quinn, et al.
Nature|December 7, 2021
Long-acting capsid inhibitor protects macaques from repeat SHIV challengesSamuel J Vidal, Elena Bekerman, Derek Hansen, et al.
Pageof 2